Paterna Biosciences Revenue and Competitors

Location

#6274

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Paterna Biosciences's estimated annual revenue is currently $5.1M per year.(i)
  • Paterna Biosciences's estimated revenue per employee is $189,444
  • Paterna Biosciences's total funding is $8M.

Employee Data

  • Paterna Biosciences has 27 Employees.(i)
  • Paterna Biosciences grew their employee count by 59% last year.

Paterna Biosciences's People

NameTitleEmail/Phone
1
Cofounder, CEOReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Co-founder and Chief Medical OfficerReveal Email/Phone
4
Co-founder and Chair Scientific AdvisorsReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Chief StaffReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Product Development ManagerReveal Email/Phone
10
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$2.8M1864%$25.1MN/A
#3
$1.4M90%N/AN/A
#4
$7.1M4639%N/AN/A
#5
$1.4M9-50%N/AN/A
#6
$1.4M9-10%N/AN/A
#7
$25.9M16711%N/AN/A
#8
$1.6M40-48%$17.8MN/A
#9
$3.4M2283%N/AN/A
#10
$2M130%N/AN/A
Add Company

What Is Paterna Biosciences?

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive.\n\nLed by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions.\n\nDid you know?\n*1 in 8 couples struggle with infertility.\n*50% of in vitro fertilization (IVF) procedures fail.\n*50% of infertility is linked to men.\n*Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then.\n\nWith a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide.\n\nWe help make parenthood possible.\n\nLearn more at www.PaternaBio.com \nContact us: [email protected]\n\nA New Paradigm in Human Reproduction.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less

keywords:N/A

$8M

Total Funding

27

Number of Employees

$5.1M

Revenue (est)

59%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M27-10%N/A
#2
$6.8M27-16%N/A
#3
$6.7M274%N/A
#4
$5.1M27-21%N/A
#5
$4.6M27-7%N/A